
SABS
Healthcare · Biotechnology · $266.7M market cap
$2.96-0.12 (-3.9%)Nov 13, 4:23 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +10.0% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.27 | -0.24 | +11.1% |
| Aug 6, 2026 | Before the open | -0.29 | -0.28 | +3.4% |
| May 12, 2026 | Time not confirmed | -0.21 | -0.35 | -69.4% |
| Mar 9, 2026 | After the close | -0.17 | -0.41 | -141.2% |
| Nov 14, 2025 | Before the open | -0.46 | 0.50 | +208.7% |
| Aug 7, 2025 | Before the open | -0.82 | -1.09 | -32.9% |
| May 9, 2025 | Before the open | -1.07 | -0.56 | +47.7% |
| Mar 26, 2025 | After the close | -1.21 | -0.98 | +18.9% |
| Nov 6, 2024 | After the close | -1.09 | -1.12 | -2.8% |
| Aug 8, 2024 | After the close | -1.15 | -0.79 | +31.3% |
| May 20, 2024 | After the close | -0.98 | -1.14 | -16.3% |
| Mar 29, 2024 | Before the open | -0.62 | -3.38 | -445.2% |
| Nov 13, 2023 | After the close | -1.15 |
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b…
| -1.01 |
| +12.2% |
| Aug 21, 2023 | Before the open | -1.45 | -1.29 | +11.0% |
| May 15, 2023 | After the close | -1.00 | -1.48 | -48.0% |
| Mar 31, 2023 | After the close | -0.16 | -0.16 | 0.0% |
| Nov 14, 2022 | After the close | -1.10 | -1.83 | -66.4% |
| Aug 10, 2022 | Before the open | -1.00 | -1.50 | -50.0% |
| May 12, 2022 | After the close | -1.10 | -1.35 | -22.7% |
| Mar 29, 2022 | After the close | -0.11 | -0.66 | -500.0% |
| Nov 22, 2021 | After the close | -0.60 | -1.20 | -100.0% |
| Aug 9, 2021 | After the close | — | -0.03 | — |
| May 21, 2021 | After the close | — | 0.84 | — |